Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age

被引:118
|
作者
Fakhoury, M
Litalien, C
Medard, Y
Cave, H
Ezzahir, N
Peuchmaur, M
Jacqz-Aigrain, E
机构
[1] Hop Robert Debre, Dept Paediat Pharmacol & Pharmacogenet, F-75019 Paris, France
[2] Hop Robert Debre, Dept Mol Biol, F-75019 Paris, France
[3] Hop Robert Debre, Clin Epidemiol Unit, F-75019 Paris, France
[4] Hop Robert Debre, Dept Anatomopathol, F-75019 Paris, France
关键词
D O I
10.1124/dmd.105.005611
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochromes P450 3A (CYP3A) and P-glycoprotein (P-gp) are mainly located in enterocytes and hepatocytes. The CYP3A/P-gp system contributes to the first-pass metabolism of many drugs, resulting in a limited bioavailability. During the neonatal period, a shift between CYP3A7, the fetal form, and CYP3A4 occurs in the liver, but data on the expression of the CYP3A/P-gp complex in the intestine are very limited. A total of 59 normal duodenal biopsies from white children aged 1 month to 17 years were studied. Localization of the proteins by immunohistochemistry analysis was performed using a polyclonal antibody, Nuage anti-CYP3A, and a monoclonal antibody, C494 anti-P-gp. The mRNA quantification was performed using highly specific real-time reverse transcription-polymerase chain reaction. Villin mRNA quantification was used for normalization. CYP3A protein was detected in all enterocytes in the samples from patients over 6 months of age, whereas it was not in younger samples. P-gp protein was expressed at the apical and upper lateral surfaces of the enterocytes. CYP3A isoforms and P-gp mRNA levels were highly variable. CYP3A4 and CYP3A5 mRNA levels were high during the first year of life and decreased with age, whereas CYP3A7 was detected at a low level in 64% of samples, whatever the age. P-gp mRNA expression level was also highly variable. Our results showed that neonates and infants had a significant expression of CYP3A and P-gp mRNA in the intestine, suggesting a different maturation profile of CYP3A and P-gp with age in the liver and the intestine.
引用
收藏
页码:1603 / 1607
页数:5
相关论文
共 50 条
  • [1] Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum
    Canaparo, Roberto
    Finnstrom, Niklas
    Serpe, Loredana
    Nordmark, Anna
    Muntoni, Elisabetta
    Eandi, Mario
    Rane, Anders
    Zara, Gian Paolo
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (11) : 1138 - 1144
  • [2] Role of human CYP3A and P-glycoprotein on the absorption of drugs
    van de Waterbeemd, H
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (01) : 1 - 1
  • [3] Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats
    Perloff, MD
    Von Moltke, LL
    Greenblatt, DJ
    XENOBIOTICA, 2004, 34 (02) : 133 - 150
  • [4] Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's disease
    Fakhoury, May
    Lecordier, Julien
    Medard, Yves
    Peuchmaur, Michel
    Jacqz-Aigrain, Evelyne
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (08) : 745 - 749
  • [5] Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein
    Richard B. Kirn
    Christoph Wandel
    Brenda Leake
    Mirjana Cvetkovic
    Martin F. Fromm
    Peter J. Dempsey
    Mark M. Roden
    Frank Belas
    Ajai K. Chaudhary
    Dan M. Roden
    Alastair J. J. Wood
    Grant R. Wilkinson
    Pharmaceutical Research, 1999, 16 (3) : 408 - 414
  • [6] Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
    Kim, RB
    Wandel, C
    Leake, B
    Cvetkovic, M
    Fromm, MF
    Dempsey, PJ
    Roden, MM
    Belas, F
    Chaudhary, AK
    Roden, DM
    Wood, AJJ
    Wilkinson, GR
    PHARMACEUTICAL RESEARCH, 1999, 16 (03) : 408 - 414
  • [7] Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro
    Wandel, C
    Kim, RB
    Guengerich, FP
    Wood, AJJ
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (08) : 895 - 898
  • [8] Interplay between CYP3A and P-Glycoprotein: The Case of Lopinavir
    van Waterschoot, Robert A. B.
    ter Heine, Rob
    Wagenaar, Els
    van der Kruijssen, Cornelia M. M.
    van Herwaarden, Antonius E.
    Huitema, Alwin D. R.
    Beijnen, Jos H.
    Schinkel, Alfred H.
    DRUG METABOLISM REVIEWS, 2009, 41 : 18 - 19
  • [9] Barrier functions of CYP3A and P-glycoprotein in monkey intestine
    Ogasawara, Akihito
    Kume, Toshiyuki
    Kazama, Emiko
    DRUG METABOLISM REVIEWS, 2006, 38 : 36 - 36
  • [10] Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues
    Matheny, CJ
    Ali, RY
    Yang, XD
    Pollack, GM
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (09) : 1008 - 1014